Clinical Trial Update: Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder [Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 2 results for Bremelanotide in premenopausal women with female sexual arousal disorder or hypoactive sexual desire disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder
• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Bremelanotide (bremelanotide)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-04-14